You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 28, 2024

Investigational Drug Information for NPC-06


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for NPC-06?

NPC-06 is an investigational drug.

There have been 4 clinical trials for NPC-06. The most recent clinical trial was a Phase 3 trial, which was initiated on August 15th 2022.

The most common disease conditions in clinical trials are Herpes Zoster, Acute Pain, and Epilepsy. The leading clinical trial sponsors are Nobelpharma and [disabled in preview].

There are two hundred and five US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for NPC-06
TitleSponsorPhase
A Phase 3 Study of NPC-06 in Patients With Pain Associated With Acute Herpes ZosterNobelpharmaPhase 3
NPC-06 to Acute Pain in Herpes ZosterNobelpharmaPhase 2
Phase II Clinical Trial of NPC-06 in Patients With Neuropathic Pain in CancerNobelpharmaPhase 2

See all NPC-06 clinical trials

Clinical Trial Summary for NPC-06

Top disease conditions for NPC-06
Top clinical trial sponsors for NPC-06

See all NPC-06 clinical trials

US Patents for NPC-06

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
NPC-06 ⤷  Try a Trial Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases Halozyme, Inc. (San Diego, CA) ⤷  Try a Trial
NPC-06 ⤷  Try a Trial Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same Platform Brightworks Two, Ltd. (Houston, TX) ⤷  Try a Trial
NPC-06 ⤷  Try a Trial Compositions and methods for treating psychiatric disorders GOSFORTH CENTRE (HOLDINGS) PTY LTD. (Maroochydore, Queensland, AU) ⤷  Try a Trial
NPC-06 ⤷  Try a Trial Compositions and methods for treating cancers CEDARS-SINAI MEDICAL CENTER (Los Angeles, CA) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for NPC-06

Drugname Country Document Number Estimated Expiration Related US Patent
NPC-06 Argentina AR082615 2030-08-09 ⤷  Try a Trial
NPC-06 Australia AU2010249031 2030-05-12 ⤷  Try a Trial
NPC-06 Australia AU2010249033 2030-05-12 ⤷  Try a Trial
NPC-06 Australia AU2011252925 2030-05-12 ⤷  Try a Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.